Outcomes | First author | Year | Types | AMSTAR 2 | GRADE |
---|---|---|---|---|---|
Mortality | Â | Â | Â | Â | Â |
All-cause mortality | Mazidi | 2018 | Milk | Moderate | Low |
CHD mortality | Mazidi | 2018 | Milk | Moderate | Low |
All cancer mortality | Lu | 2016 | Milk | High | Low |
Prostate cancer mortality | Lu | 2016 | Milk | High | Very low |
Prostate cancer mortality | Lu | 2016 | Skim/low-fat milk | High | Very low |
Cancer | Â | Â | Â | Â | Â |
CRC | Barrubes | 2019 | Milk | Low | Moderate |
CRC | Barrubes | 2019 | Low-fat milk | Low | Low |
Prostate cancer | Aune | 2015 | Milk | Low | Moderate |
DLBCL | Wang | 2016 | Milk | Critically low | Low |
Gastric cancr | Wang | 2018 | Milk | Critically low | Moderate |
Bladder Cancer | Bermejo | 2019 | Milk | Moderate | Moderate |
Bladder Cancer | Bermejo | 2019 | Whole milk | Moderate | Low |
Breast cancer | Chen | 2019 | Low-fat milk | Critically low | Very low |
Breast cancer | Chen | 2019 | Milk | Critically low | Low |
Breast cancer | Wu | 2016 | Milk | Moderate | Moderate |
Breast cancer | Wu | 2016 | Skim milk | Moderate | Moderate |
Endometrial cancer | Li | 2017 | Milk | Moderate | Moderate |
ESCC | Li | 2016 | Milk | High | Moderate |
FL | Wang | 2016 | Milk | Critically low | Very low |
HCC | Yang | 2017 | Milk | Low | Moderate |
Lung cancer | Yang | 2016 | Milk | Moderate | Moderate |
Lung cancer | Yang | 2016 | Low-fat milk | Moderate | Low |
NHL | Sergentanis | 2019 | Milk | Low | Low |
Ovarian cancer | Liu | 2015 | Low-fat/skim milk | Critically low | Low |
Ovarian cancer | Liu | 2015 | Milk | Critically low | Moderate |
Pancreatic cancer | Genkinger | 2014 | Milk | Critically low | Moderate |
Pancreatic cancer | Genkinger | 2014 | Whole milk | Critically low | Moderate |
Pancreatic cancer | Genkinger | 2014 | Low-fat milk | Critically low | Moderate |
SLL/CLL | Wang | 2016 | Milk | Critically low | Very low |
Cardiovascular outcomes | Â | Â | Â | Â | Â |
CVD | Guo | 2017 | Milk | High | Low |
CVD | Soedamah-Muthu | 2011 | Milk | Low | Low |
CHD | Gholami | 2017 | Milk | Moderate | Moderate |
Arterial Stiffness | Diez-Fernandez | 2019 | Milk | High | Moderate |
Hypertension | Soedamah-Muthu | 2012 | Milk | Low | Moderate |
Stroke | de Goede | 2016 | Milk | Moderate | Moderate |
Stroke | de Goede | 2016 | High-fat milk | Moderate | Low |
Stroke | de Goede | 2016 | Low-fat milk | Moderate | Low |
Stroke | Gholami | 2017 | Milk | Moderate | Moderate |
Metabolic outcomes | Â | Â | Â | Â | Â |
Abdominal obesity | Lee | 2018 | Milk | Moderate | Moderate |
T2DM | Gijsbers | 2016 | Milk | Moderate | Low |
T2DM | Gijsbers | 2016 | Low-fat milk | Moderate | Low |
T2DM | Gijsbers | 2016 | High-fat milk | Moderate | Low |
Hypertriacylglycerolaemia | Lee | 2018 | Milk | Moderate | Low |
Metabolic Syndrome | Mena | 2019 | Milk | Critically low | Moderate |
Metabolic Syndrome | Lee | 2018 | Milk | Moderate | Moderate |
Obesity | Wang | 2016 | Milk | Low | Moderate |
T2DM | Tian | 2017 | Whole milk | Low | Low |
Skeletal outcomes | Â | Â | Â | Â | Â |
Hip fracture | Malmir | 2019 | Milk | Low | Low |
Osteoporosis | Malmir | 2019 | Milk | Low | Moderate |
Vertebral fracture | Matia | 2019 | Milk | Low | Very low |
Neurological outcomes | Â | Â | Â | Â | Â |
Alzheimer's disease | Wu | 2016 | Milk | Moderate | Very low |
Cognitive Disorders | Wu | 2016 | Milk | Moderate | Low |
Cognitive function | Lee | 2018 | Milk | Moderate | Very low |
Parkinson’s disease | Jiang | 2014 | Milk | Low | Low |
Dementia | Wu | 2016 | Milk | Moderate | Very low |
Infant outcomes | Â | Â | Â | Â | Â |
FDA | Griebler | 2016 | Milk | Low | Low |
T1DM | Griebler | 2016 | Milk | Low | Low |
Other outcomes | Â | Â | Â | Â | Â |
Acne | Aghasi | 2019 | Milk | Low | Moderate |
Dental erosion | Li | 2012 | Milk | Critically low | Very low |
Endometriosis | Hoorsan | 2017 | Milk | Low | Very low |